Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Glaxosmithkline (GSK) Share News

Market has doubts on GSK's long-term growth prospects - Shore

27th Sep 2022 10:06

(Alliance News) - Analysts at Shore Capital Markets on Tuesday backed GSK PLC's near and medium-term prospects, but noted the pharmaceutical firm has some work to do to convince the market of its long-term potential. Read More

TOP NEWS: Unilever CEO Alan Jope to step down next year

26th Sep 2022 09:11

(Alliance News) - Unilever PLC on Monday said Chief Executive Alan Jope will step down at the end of next year, after five years in the post. Read More

TOP NEWS: GSK names Burberry's Julie Brown as new CFO from May

26th Sep 2022 08:55

(Alliance News) - GSK PLC on Monday announced a change in leadership, after its Chief Financial Officer Iain Mackay decided to retire. Read More

LONDON BRIEFING: Unilever CEO to step down; RPS backs new takeover bid

26th Sep 2022 07:47

(Alliance News) - All eyes will be on the pound when traders in Europe return to desks on Monday, after the UK currency fell to an all-time low during the Asian session. Read More

GSK cancer drug Zejula to be reviewed by US health watchdog

23rd Sep 2022 06:57

(Alliance News) - GSK PLC on Thursday said its cancer drug Zejula will be reviewed by the US Food & Drug Administration for overall survival data for patients with ovarian cancer. Read More

TOP NEWS: GSK signs licence deal for Spero's tebipenem HBr antibiotic

22nd Sep 2022 08:43

(Alliance News) - GSK PLC on Thursday said it has signed an exclusive licence agreement with Massachusetts-based biotechnology firm Spero Therapeutics for the latter's tebipenem pivoxil hydrobromide, or tebipenem HBr. Read More

TOP NEWS SUMMARY: Haleon makes positive start separate from GSK

20th Sep 2022 10:59

(Alliance News) - The following is a summary of top news stories Tuesday. Read More

TOP NEWS: Haleon makes good earnings debut with interim revenue rise

20th Sep 2022 09:08

(Alliance News) - Haleon PLC on Tuesday reported a strong performance in the first half of 2022 in its first earnings report since being split from GSK PLC in July and separately listed, noting double-digit revenue growth and profit rise. Read More

LONDON BRIEFING: Haleon reports double-digit revenue growth

20th Sep 2022 07:51

(Alliance News) - Stocks in London are set to open higher on Tuesday, as markets in London return to action following a bank holiday for the state funeral of Queen Elizabeth II. Read More

TOP NEWS: Two AstraZeneca drugs get recommendations for EU approval

16th Sep 2022 08:16

(Alliance News) - AstraZeneca PLC on Friday said it received two recommendations for drug approvals in the EU, while a drug for blood disorder paroxysmal nocturnal haemoglobinuria met its primary endpoint in a phase three trial. Read More

LONDON BROKER RATINGS: Credit Suisse cuts AstraZeneca and raises GSK

15th Sep 2022 09:30

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Friday: Read More

LONDON BROKER RATINGS: Stifel downgrades IAG, easyJet and Ryanair

14th Sep 2022 09:40

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday: Read More

GSK says niraparib shows sustained benefit in ovarian cancer patients

9th Sep 2022 14:34

(Alliance News) - GSK PLC on Friday said niraparib, sold under the brand name Zejula, has shown long-term survival benefit in an ovarian cancer study. Read More

LONDON BROKER RATINGS: Morgan Stanley cuts ITV to 'underweight'

8th Sep 2022 09:22

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning: Read More

LONDON BROKER RATINGS: UBS raises Admiral; Morgan Stanley cuts Astra

7th Sep 2022 09:47

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday afternoon: Read More

GSK malaria vaccine gets WHO boost; FDA reviews kidney disease drug

6th Sep 2022 14:07

(Alliance News) - GSK PLC on Tuesday said the World Health Organisation made it easier for its malaria vaccine Mosquirix to be rolled out while the US Food & Drug Administration is reviewing the firm's kidney disease drug, daprodustat. Read More

GSK to present data on ovarian and endometrial cancer drugs in Paris

1st Sep 2022 10:13

(Alliance News) - Biopharma firm GSK PLC on Thursday said it will present new data on its ovarian cancer and endometrial cancer drugs from September 9 to 13 at the European Society for Medical Oncology Congress 2022 in Paris. Read More

LONDON MARKET CLOSE: FTSE 100 keeps head above water as pound sinks

19th Aug 2022 17:07

(Alliance News) - The FTSE 100 managed to outperform European counterparts on Friday due to weakness in the pound as consumer confidence in the UK fell to a record low, while attention turns to next week's Jackson Hole Symposium. Read More

LONDON MARKET MIDDAY: Weaker pound unable to keep FTSE in green

19th Aug 2022 12:06

(Alliance News) - London's FTSE 100 outperformed peers but was unable to stave off selling pressure in a tough session for European stocks on Friday, despite sitting just above positive territory for much of the late-morning's trade. Read More

LONDON BROKER RATINGS: Jefferies likes AO, Berenberg lifts Devolver

18th Aug 2022 09:43

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday: Read More

FTSE 100 Latest
Value8,774.65
Change-17.15